AEPCX
Price
$59.33
Change
-$0.17 (-0.29%)
Updated
Aug 14 closing price
Net Assets
135.65B
GSINX
Price
$22.61
Change
+$0.02 (+0.09%)
Updated
Aug 14 closing price
Net Assets
54.13B
Interact to see
Advertisement

AEPCX vs GSINX

Header iconAEPCX vs GSINX Comparison
Open Charts AEPCX vs GSINXBanner chart's image
American Funds EUPAC C
Price$59.33
Change-$0.17 (-0.29%)
VolumeN/A
Net Assets135.65B
Goldman Sachs GQG Ptnrs Intl Opps I
Price$22.61
Change+$0.02 (+0.09%)
VolumeN/A
Net Assets54.13B
AEPCX vs GSINX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
AEPCX vs. GSINX commentary
Aug 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Buy and GSINX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 136B vs. GSINX (54.1B). GSINX pays higher dividends than AEPCX: GSINX (1.87) vs AEPCX (0.17). AEPCX was incepted earlier than GSINX: AEPCX (24 years) vs GSINX (9 years). AEPCX (1.57) is less costly to investors than GSINX (0.91). GSINX is a more actively managed with annual turnover of: 88.00 vs. AEPCX (35.00). GSINX has a lower initial minimum investment than AEPCX: GSINX (0) vs AEPCX (250). AEPCX annual gain was more profitable for investors over the last year : 8.15 vs. GSINX (0.47). GSINX return over 5 years is better than : 51.45 vs. AEPCX (8.18).
AEPCXGSINXAEPCX / GSINX
Total Expense Ratio1.570.88178%
Annual Report Gross Expense Ratio1.570.91173%
Fund Existence24 years9 years-
Gain YTD14.82515.96593%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets136B54.1B251%
Annual Yield % from dividends0.171.879%
Returns for 1 year8.150.471,726%
Returns for 3 years20.7741.4550%
Returns for 5 years8.1851.4516%
Returns for 10 years25.60N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DRUG42.542.00
+4.92%
Bright Minds Biosciences
IPSC0.550.02
+3.15%
Century Therapeutics
PNFP93.420.14
+0.15%
Pinnacle Financial Partners
MAYAU10.66N/A
N/A
Maywood Acquisition Corp
STGW5.53-0.15
-2.64%
Stagwell